Air Liquide has entered into exclusive negotiations with French private equity firm Hivest Capital Partners for the divestment of its subsidiary CRYOPDP, a supplier of tailor-made life sciences and healthcare solutions.
The decision highlights Air Liquide’s strategy to regularly review its asset portfolio in order to focus on key businesses and geographies to maximise its performances.
The transaction is subject to the signature of a final and definite agreement between the two companies and will be carried out in the framework of the relevant social processes and ongoing dialogue with the employee representatives’ bodies.
... to continue reading you must be subscribed
